SGN-40 shows evidence of activity in patients with relapsed non-Hodgkin lymphoma: Final results of a phase I dose-escalation study Advani, R., Forero-Torres, A., Furman, R. R., Rosenblatt, J. D., Younes, A., Harrop, K., Whiting, N. C., Drachman, J. G. OXFORD UNIV PRESS. 2008: 115

View details for Web of Science ID 000256693500116